Outcomes of Treatment With Simvastatin in Critically Ill Patients With COVID-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Simvastatin in Critically Ill Patients with Covid-19
N. Engl. J. Med 2023 Oct 25;[EPub Ahead of Print], TE Hills, E Lorenzi, LR Berry, M Shyamsundar, F Al-Beidh, D Annane, Y Arabi, D Aryal, C Au, A Beane, Z Bhimani, M Bonten, CA Bradbury, FM Brunkhorst, A Burrell, M Buxton, CS Calfee, M Cecconi, AC Cheng, ME Cove, MA Detry, LJ Estcourt, M Fitzgerald, EC Goligher, H Goossens, C Green, R Haniffa, DA Harrison, M Hashmi, AM Higgins, DT Huang, N Ichihara, D Jayakumar, PS Kruger, F Lamontagne, L Lampro, PR Lawler, JC Marshall, AJ Mason, A McGlothlin, S McGuinness, ZK McQuilten, BJ McVerry, PR Mouncey, S Murthy, MD Neal, AD Nichol, CM O'Kane, RL Parke, JC Parker, E Rabindrarajan, LF Reyes, KM Rowan, H Saito, M Santos, CT Saunders, CW Seymour, M Shankar-Hari, P Sinha, BT Thompson, AF Turgeon, AM Turner, FV van de Veerdonk, S Weis, IS Young, R Zarychanski, RJ Lewis, CJ McArthur, DC Angus, SM Berry, LPG Derde, SA Webb, AC Gordon, DF McAuleyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.